SCHOLAR ROCK HOLDING CORP (SRRK) Fundamental Analysis & Valuation

NASDAQ:SRRK • US80706P1030

Current stock price

47.645 USD
-1.16 (-2.39%)
Last:

This SRRK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SRRK Profitability Analysis

1.1 Basic Checks

  • SRRK had negative earnings in the past year.
  • In the past year SRRK has reported a negative cash flow from operations.
  • In the past 5 years SRRK always reported negative net income.
  • SRRK had a negative operating cash flow in each of the past 5 years.
SRRK Yearly Net Income VS EBIT VS OCF VS FCFSRRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of SRRK (-93.49%) is worse than 73.89% of its industry peers.
  • SRRK has a Return On Equity of -153.95%. This is in the lower half of the industry: SRRK underperforms 64.41% of its industry peers.
Industry RankSector Rank
ROA -93.49%
ROE -153.95%
ROIC N/A
ROA(3y)-47.57%
ROA(5y)-41.66%
ROE(3y)-64.04%
ROE(5y)-60.37%
ROIC(3y)N/A
ROIC(5y)N/A
SRRK Yearly ROA, ROE, ROICSRRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • SRRK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SRRK Yearly Profit, Operating, Gross MarginsSRRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SRRK Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for SRRK has been increased compared to 1 year ago.
  • Compared to 5 years ago, SRRK has more shares outstanding
  • Compared to 1 year ago, SRRK has a worse debt to assets ratio.
SRRK Yearly Shares OutstandingSRRK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SRRK Yearly Total Debt VS Total AssetsSRRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • SRRK has an Altman-Z score of 14.52. This indicates that SRRK is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of SRRK (14.52) is better than 85.11% of its industry peers.
  • SRRK has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
  • SRRK has a worse Debt to Equity ratio (0.41) than 70.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 14.52
ROIC/WACCN/A
WACCN/A
SRRK Yearly LT Debt VS Equity VS FCFSRRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

2.3 Liquidity

  • A Current Ratio of 6.95 indicates that SRRK has no problem at all paying its short term obligations.
  • SRRK has a Current ratio of 6.95. This is in the better half of the industry: SRRK outperforms 66.54% of its industry peers.
  • A Quick Ratio of 6.95 indicates that SRRK has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 6.95, SRRK is doing good in the industry, outperforming 66.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.95
Quick Ratio 6.95
SRRK Yearly Current Assets VS Current LiabilitesSRRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SRRK Growth Analysis

3.1 Past

  • SRRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.43%.
EPS 1Y (TTM)-39.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • SRRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.50% yearly.
  • SRRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 449.08% yearly.
EPS Next Y6.48%
EPS Next 2Y17.6%
EPS Next 3Y21.29%
EPS Next 5Y21.5%
Revenue Next Year13538.7%
Revenue Next 2Y2865.44%
Revenue Next 3Y1179.01%
Revenue Next 5Y449.08%

3.3 Evolution

SRRK Yearly Revenue VS EstimatesSRRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2019 2020 2021 2022 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
SRRK Yearly EPS VS EstimatesSRRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. SRRK Valuation Analysis

4.1 Price/Earnings Ratio

  • SRRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SRRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRRK Price Earnings VS Forward Price EarningsSRRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRRK Per share dataSRRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SRRK's earnings are expected to grow with 21.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.6%
EPS Next 3Y21.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SRRK Dividend Analysis

5.1 Amount

  • SRRK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SRRK Fundamentals: All Metrics, Ratios and Statistics

SCHOLAR ROCK HOLDING CORP

NASDAQ:SRRK (4/7/2026, 9:38:51 AM)

47.645

-1.16 (-2.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03
Earnings (Next)05-12
Inst Owners124.75%
Inst Owner Change0%
Ins Owners3.36%
Ins Owner Change0%
Market Cap5.47B
Revenue(TTM)N/A
Net Income(TTM)-377.94M
Analysts87.27
Price Target56.81 (19.24%)
Short Float %12.93%
Short Ratio11.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.05%
Min EPS beat(2)-5.19%
Max EPS beat(2)3.09%
EPS beat(4)2
Avg EPS beat(4)-11.51%
Min EPS beat(4)-44.57%
Max EPS beat(4)3.09%
EPS beat(8)4
Avg EPS beat(8)-7.91%
EPS beat(12)7
Avg EPS beat(12)-2.47%
EPS beat(16)10
Avg EPS beat(16)4.95%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.59%
PT rev (3m)16.23%
EPS NQ rev (1m)5.75%
EPS NQ rev (3m)6.13%
EPS NY rev (1m)0%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 22.3
P/tB 22.3
EV/EBITDA N/A
EPS(TTM)-3.43
EYN/A
EPS(NY)-3.21
Fwd EYN/A
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)-1.75
OCFYN/A
SpS0
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -93.49%
ROE -153.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.57%
ROA(5y)-41.66%
ROE(3y)-64.04%
ROE(5y)-60.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.06%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.95
Quick Ratio 6.95
Altman-Z 14.52
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)14.34%
Cap/Depr(5y)103.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
EPS Next Y6.48%
EPS Next 2Y17.6%
EPS Next 3Y21.29%
EPS Next 5Y21.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year13538.7%
Revenue Next 2Y2865.44%
Revenue Next 3Y1179.01%
Revenue Next 5Y449.08%
EBIT growth 1Y-52.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-60.77%
EBIT Next 3Y13.04%
EBIT Next 5YN/A
FCF growth 1Y-38.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.37%
OCF growth 3YN/A
OCF growth 5YN/A

SCHOLAR ROCK HOLDING CORP / SRRK Fundamental Analysis FAQ

What is the fundamental rating for SRRK stock?

ChartMill assigns a fundamental rating of 2 / 10 to SRRK.


What is the valuation status for SRRK stock?

ChartMill assigns a valuation rating of 1 / 10 to SCHOLAR ROCK HOLDING CORP (SRRK). This can be considered as Overvalued.


Can you provide the profitability details for SCHOLAR ROCK HOLDING CORP?

SCHOLAR ROCK HOLDING CORP (SRRK) has a profitability rating of 0 / 10.


How financially healthy is SCHOLAR ROCK HOLDING CORP?

The financial health rating of SCHOLAR ROCK HOLDING CORP (SRRK) is 5 / 10.